Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tongue_CMC048_Danish_Landrace_QStarXL

ABSTRACT: biosource.anatomical.site.ontology.entry: EV:0100058 tongue developmental.stage.ontology.entry: pathology.ontology.entry:

INSTRUMENT(S): QSTAR XL

ORGANISM(S): Sus Scrofa

SUBMITTER:

PROVIDER: PAe000478 | PeptideAtlas |

REPOSITORIES: PeptideAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	PAe000478_README	Other
	PAe000478_Search_Results_9040_201507220227.properties	Other
	PAe000478_Search_Results_9040_201507220227.tar.gz	Other
	PAe000478_prot_9040_201507220227.properties	Other
	PAe000478_prot_9040_201507220227.tar.gz	Other

Items per page:

1 - 5 of 6

Similar Datasets

RNA-seq data set of EGFR mutant human non-small cell lung cancer cell lines PC9, HCC827, HCC4006 after NF2 knockout, YAP1 or WWTR1 overexpression or osimertinib treatment

Project description:Experiment was designed to study the effect of Hippo pathway on osimertinib resistance in non-small cell lung cancer cell lines. The specific comparisons investigated were: PC-9: NTC vs NF2 KO, EV vs YAP1 OE, EV vs WWTR1 OE, EV DMSO treated vs EV osimertinib treated HCC827: NTC vs NF2 KO, EV vs YAP1 OE, EV vs WWTR1 OE,EV DMSO treated vs EV osimertinib treated HCC4006: NTC vs NF2 KO, EV vs YAP1 OE, EV vs WWTR1 OE, EV DMSO treated vs EV osimertinib treated

2024-07-01 | E-MTAB-13831 | biostudies-arrayexpress

Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma

Project description:This study aimed to understand the role of ILF2 upregulation in metastatic melanoma cutaneous progression and DNA damage response. The goal of RPPA analysis was to determine the protein expression profiles in DP-0574 and IM-0223 melanoma cell lines with ILF2 overexpression (ILF2-OV) or control empty vector (EV). By analysis of RPPA in both metastatic melanoma cell lines, we found that ILF2-OV controls significantly increased RAD50 expression.

2022-04-15 | GSE159692 | GEO

4ed308de-70b0-456c-a516-8ff3eb1d8826 - samples

Project description:Ovarian cancer EV RNA-seq

| EGAD00001008972 | EGA

Downregulation of the Ubiquitin-E3 Ligase KPC1 promotes glioblastoma progression through upregulation of SerpinE1 [array]

Project description:Two glioblastoma cell lines (LN18 and HS863) were stable transfected with control empty vector (EV) or RNF123-vector (KPC1). The objective of this experiment was to determine NFKB1-targets regulated by RNF123 overexpression in glioblastoma cell lines. To do that LN18 and HS863 cell lines with RNF123 overexpression were compared to control empty vector. In the present study, we utilized the combination of RPPA and RNA-Sequencing. By comparing both datasets, we identified commonly proteins and genes differentially expressed in control versus RNF123-overexpressing cells.

2020-06-17 | GSE131399 | GEO

Packaging of DNA:RNA hybrids in extracellular vesicles and their horizontal transfer in cancer

Project description:RNAs isolated from ZR751 (acceptors/responders) and BT474 (non-acceptors/non-responders) cells following education with EV-Hybridlow (EV-DNA from normoxic cancer cells) and EV-Hybridhigh (EV-DNA from IH-derived cancer cells) were sequenced.

2020-12-31 | E-MTAB-7586 | biostudies-arrayexpress

Evaluation of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.

Project description:Interventions: Observation: metastatic colorectal cancer patients who have been treated in first-line with FOLFOXIRI (a triple drug combination of irinotecan 165 mg/square meter (sqm) endovenous (ev) in 1 hour, oxaliplatin 85 mg/sqm ev in 2 hours and 5-fluorouracil 3200 mg/sqm as a 48-hour continous infusion ev plus leucovorin 200 mg/sqm ev in 2 hours, every 14 days for 12 cycles) and who underwent radical surgical resection of metastases will be followed up yearly for 5 years after the diagnosis of disease to collect their survival status. Primary outcome(s): Overall survival[Anually for 5 years after diagnosis] Study Design: Purpose: Natural history;Duration: Longitudinal;Selection: Defined population;Timing: Prospective

| 2454318 | ecrin-mdr-crc

Populus deltoides cultivar:EV

Project description:Populus deltoides EV transcriptome - EV A1 leaf

| PRJNA520076 | ENA

Populus deltoides cultivar:EV

Project description:Populus deltoides EV transcriptome - EV B1 stem

| PRJNA520091 | ENA

Populus deltoides cultivar:EV

Project description:Populus deltoides EV transcriptome - EV B2 stem

| PRJNA520092 | ENA

Populus deltoides cultivar:EV

Project description:Populus deltoides EV transcriptome - EV B1 leaf